ACACA and hereditary leiomyomatosis and renal cell cancer: Decreased AMPK activity in hereditary leiomyomatosis renal cell cancer (HLRCC) leads to the elevated activity of ACC1, which contributes to the oncogenic growth of HLRCC (76).